In a trial of low-grade Ta bladder cancer, photocoagulation was noninferior to standard TURBT in maintaining recurrence-free survival. Office-based laser photocoagulation provides 12-month ...

A phase 2 trial evaluated the effectiveness and safety of neoadjuvant intravesical mitomycin-C instillation in patients with urothelial non-muscle invasive bladder cancer.

筋層浸潤性膀胱癌（MIBC）を対象とするフェーズ2試験HORN GU16-257の中間解析において、経尿道的膀胱腫瘍切除術（TURBT）＋ゲムシタビン＋シスプラチンにニボルマブを加えることにより、48％の患者が厳格に規定された臨床的完全奏効（cCR）を達成した。

Busoga Anglican Diocese bishop the Rt. Rev. Dr. Paul Samson Naimanhye has undergone successful surgery and is reportedly recovering. The prelate, according to reports, underwent a transurethral ...

EORTC GUCG 2418 - STARBURST: Strategies for treatment adaptation following re-evaluation of the bladder after using primary neoadjuvant systemic therapies—An EORTC platform trial. This is an ASCO ...

The GAIN trial: Gemcitabine alternating with intravesical BCG randomized against BCG alone for patients with recurrent “BCG-exposed” high-grade non-muscle invasive bladder cancer (NMIBC) (ALLIANCE ...